`
`07-03-2002
`
`U 8. Patents: TMo1eITM Mail Rep: D1. «:5
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`In the Matter of Application Serial No. 78/089,873
`Published in the Official Gazette of June 4, 2002
`Atty. Ref.: 312.0941
`_ _ _ _ . _ _ . . _ . _ _ . . . _ _ _ . _ . . _ . . _-x
`
`IPR PHARMACEUTICALS, INC. ,
`
`Opposer,
`
`Opposition No. :
`
`-aga1nSt—'
`
`PHARMACIA & UPJOHN COMPANY,
`
`Applicant.
`
`..........................
`
`Commissioner for Trademarks
`
`2900 Crystal Drive
`Arlington, VA 22202-3513
`
`Attn: BOX TTAB FEE
`
`“EXPRESS MAIL" Label NO . : EV]. 1 8 9 5 27 7 SUS
`I hereby certify that this paper or fee is being deposited with the United Slates Postal
`Service “Exmess Mail
`st Office to Addresses" service under 37 C.F.R. § 1.10 on the
`date indicated below :1 is addressd to the Com ' sioner for Trademarks. 2900
`Crystal Drive, Arling
`, VA 22202-3 .
`Q
`
`
`
`N_(_ LTICE OF OPPOSITION
`
`IPR Pharmaceuticals, Inc., a Puerto Rican corporation, with a place of business located
`
`at Sabana Gardens Industrial Park, P.0. Box 1967, Carolina, Puerto Rico 00984 [hereinafter
`
`"0pposer"], believes that it will be damaged by registration of the trademark “VIGENT”, as
`
`shown in Application Serial No. 78/089,873, and hereby opposes same.
`
`As grounds for opposition, it is alleged that:
`
`07/10/8002 HPETTY
`
`00000102 78089873
`
`01 FC:377
`
`300.00 OP
`
`91321-1v1
`
`
`
`«
`
`n
`
`It
`
`‘
`
`.
`
`1.
`
`Applicant has filed an application in the United States Patent and Trademark Office,
`
`Serial No. 78/089,873, filed October 24, 2001, for registration of the trademark “VIGENT” on
`
`the Principal Register in respect of "pharmaceutical preparations, namely preparations for the
`
`treatment of irfectious diseases, cancer, ophthalmological conditions and diseases, central nervous
`
`systems diseases and disorders, Parkinson’s disease, cardiovascular diseases and conditions,
`
`migraines, analgesics; preparations for the treatment and symptoms of diabetes; hormonal
`
`preparations; anti~inflammatory pharmaceutical preparations" (lnt'l. Class 5), on the basis of an
`
`alleged bona fide intention to use said mark in commerce.
`
`2.
`
`Upon information and belief, applicant did not use its alleged trademark “VIGENT”
`
`anywhere in the United States, or in commerce, prior to its aforementioned application filing date.
`
`3.
`
`Opposer is a leading producer and distributor of high—quality pharmaceutical
`
`products.
`
`4.
`
`Opposer has applied to register the trademark “VIBRENT” on the Principal Register
`
`of the United States Patent and Trademark Office, Ser. No. 75/878,420, filed December 21, 1999
`
`in respect of “pharmaceutical preparations for the treatment of cardiovascular diseases” (Int’l. Cl.
`
`5). Said application has been “allowed” by the United States Patent and Trademark Office.
`
`5.
`
`There is no issue of priority since the filing date of applicant's “VIGENT”
`
`trademark application is subsequent to the filing date of Opposer’s “VIBRENT” trademark
`
`application.
`
`6.
`
`Opposer’s pleaded mark possesses a high degree of inherent distinctiveness and
`
`represents or will represent an extremely valuable asset and symbol of the goodwill of its business
`
`by identifying goods which have their source of origin exclusively with opposer, and by
`
`distinguishing such goods from those of others.
`
`91323111
`
`2
`
`
`
`r
`
`4
`
`7.
`
`Applicant's alleged trademark “VIGENT” is confusingly similar to opposer's
`
`pleaded mark “VIBRENT" in sound, appearance and/or commercial impression.
`
`8.
`
`The respective goods of the opposer and the applicant are identical, related and/or
`
`complementary and would travel through the same channels of trade and/or be sold to the same
`
`general class of purchasers and/or users of pharmaceuticals and medical products.
`
`9.
`
`Under the “doctrine of greater care”, the applicant has a duty to adopt a trademark
`
`for its aforementioned goods which is clearly distinguishable from opposer’s trademark for similar
`
`pharmaceutical preparations.
`
`10.
`
`Under the “doctrine of greater care”, applicant’s alleged trademark “VIGENT" is
`
`likely to cause confusion, or to cause mistake, or to deceive with respect
`
`to opposer’s trademark
`
`“VIBRENT.”
`
`ll.
`
`Applicant's alleged trademark is calculated or likely to cause confusion or mistake
`
`or deception of purchasers as to the respective marks of the opposer and the applicant, and also
`
`as to the source of origin or sponsorship of the goods for which such marks are used, or are
`
`intended to be used.
`
`12.
`
`Applicant's alleged trademark is calculated or likely to cause irreparable loss,
`
`injury and damage to opposer's business and to the goodwill thereto appertaining as symbolized
`
`and recognized by its aforementioned mark.
`
`13.
`
`Applicant's alleged trademark is a colorable imitation or misappropriation of
`
`opposer's pleaded mark, and will enable applicant to reap where it has not sown by trading on the
`
`goodwill of opposer's business as symbolized and recognized by its aforementioned mark.
`
`91323V1
`
`3
`
`
`
`WHEREFORE, opposer, by its undersigned attorneys, prays that its opposition to
`
`Application Serial No. 78/089,873 be sustained and that the Trademark Trial and Appeal Board
`
`grant any and all further relief to the Opposer that the Board finds to be necessary and just in the
`
`circumstances.
`
`A duplicate copy of this Notice of Opposition is enclosed, along with a check for $300 in
`
`payment of the official filing fee. The Commissioner is authorized to charge our Deposit Account
`
`No. 20-1439, for any other fees required to be paid in connection with this proceeding.
`
`Respectfully submitted,
`
`TRADEMARK & PATENT COUNSELORS
`
`OF A1\/IERICA, P.C.
`
`Dated: July 1, 2002
`
`.
`
`By
`
`/h\al'k ii ~ Dflflfl
`
`Mark I. Peroff
`Keith E. Danish
`
`J ‘g\a¢“L
`
`I
`
`915 Broadway
`19th Floor
`
`New York, NY 10010-7108
`
`Tel. No.2 (212) 387-0247
`
`Attorneys for Opposer
`
`91323111
`
`4